Eliquis is a blood thinner that is marketed by Bristol Myers Squibb. It carries a list price of over $7,000 per year. We investigated the patenting strategies around Eliquis. Here's what we found: 📄43 patent applications have been filed 📄22 patents have been granted These

"The Rampant Reach of Pharma's Hidden Hand," P4AD's newest update to “The Hidden Hand," documents and exposes six industry-funded front groups advancing pro-pharma positions that support higher drug prices. Read the report: tinyurl.com/39sx6knn

Six supposed patient advocacy groups are closely linked to drugmakers and pushing industry-aligned agendas, according to a new report. levernews.com/the-pharma-pup…

Buyer beware! 🔥🔥🔥 Not all patient groups are what they seem!

"The Rampant Reach of Pharma's Hidden Hand," P4AD's newest report exposes six industry-funded front groups advancing pro-pharma positions that support higher drug prices. Get the scoop: tinyurl.com/39sx6knn

According to this new study prescription drugs have risen on average from from $1,785 in 2005 to $5,954 in 2025. managedhealthcareexecutive.com/view/milliman-…

Prescription for Higher Prices: The Real Cost of the EPIC Act via Arnold Ventures: arnoldventures.org/stories/prescr…

3/10 didn't take their medicine due to cost in the last year: 21% said they have not filled a prescription, 21% who took an over-the-counter drug instead & 12% who say they have cut pills in half or skipped a dose as a cost-cutting measure Forbes

A new Axios piece covers the $4.8B handout to pharma that would expand exemptions from Medicare negotiation — As P4AD’s Merith Basey MSc put it, this bill goes “in the opposite direction that voters are demanding.” tinyurl.com/4bhzaj39

Don't be fooled: pharma makes a profit in every country in the world. Americans want lower prices HERE not higher prices for patients ELSEWHERE.

The Patent Office is Putting Pharma Profits over Patients’ Lives. It must reclaim its mission by rolling back recent changes, reprioritizing patent quality, & putting innovation and competition ahead of pharma profits. dcjournal.com/patent-office-…

🔥🔥🔥

The June 25 edition of The Latino Newsletter is an opinion piece by Sonia Vega, a mother and wife from Phoenix, Arizona. Even with a full-time job and health insurance, she still can't afford her diabetes medication due to its high cost. thelatinonewsletter.org/p/latino-patie…

Just days after patients helped keep the pharma-backed ORPHAN Cures Act out of the Senate reconciliation bill text, lawmakers have brought it back — but we still have a chance to stop it. “Patients are infuriated to see the Senate cave to Big Pharma by reviving the ORPHAN Cures

🚨LAST MINUTE... drug companies put a new loophole back into the budget bill. WHAT DOES IT DO: Let's the most profitable drugs keep monopoly to set their price instead of negotiating with Medicare. CONSEQUENCES: CBO says $5B from taxpayers & higher drug prices for seniors.

Don't be deceived: OPRHAN Cures is a harmful $5 billion giveaway to pharma & will increase drug prices for patients. Tell your Senator to vote against its inclusion in the reconciliation bill. actionnetwork.org/letters/contac…

Reforming the patent system is key to lower prescription drug costs - and its bipartisan! freopp.org/oppblog/prescr…

"'This policy will basically provide a loophole for pharma to enable them to keep more expensive drugs on the market at high prices,' said Merith Basey, executive director of Patients for Affordable Drugs." Merith Basey MSc

New from Joseph Choi 최명훈: "This decision marks the 10th court ruling in favor of patients" Merith Basey MSc: "By upholding the lower court’s decision, the U.S. Court of Appeals is siding with American patients who deserve a much better deal" thehill.com/policy/healthc…

THREE more wins for US Patients V Big Pharma.